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Edited by Masayuki MiyasakaAbstract Phosphatidylinositol 3-kinase (PI3K) and its eﬀector
protein kinase B (PKB/c-akt) have been implicated as critical
mediators of cytokine-induced survival signals. In this study,
we have utilized an IL-5 dependent hematopoietic cell line
(TF-1) to investigate the signaling events involved in cytokine-
dependent erythroblast survival. We demonstrate that IL-5 res-
cues TF-1 cells from apoptosis through a PI3K/PKB-dependent
signaling pathway. Cytokine-withdrawal leads to activation of
the Forkhead transcription factor FOXO3a and subsequent
expression of the pro-apoptotic Bcl-2 family member Bim. Bim
is itself suﬃcient to induce apoptosis in these cells. Importantly,
activation of an inducible active FOXO3a mutant is alone suﬃ-
cient for upregulation of Bim expression and induction of apop-
tosis. These data deﬁne a mechanism by which survival factors
inhibit the default apoptotic pathway and can regulate TF-1
erythroblast survival.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Survival of hematopoietic cells is often dependent on the
supply of cytokines, which regulate intracellular signal trans-
duction pathways involved in the suppression of apoptosis
[1]. Interleukin-5 (IL-5) is a T helper-2-derived cytokine
involved in diﬀerentiation and survival of eosinophils and
B-cells [2–4]. Its receptor, together with the receptors for
Interleukin-3 (IL-3) and granulocyte/macrophage colony-
stimulating factor (GM-CSF), consists of a cytokine speciﬁc
a-chain and a common b-chain (bc). Cytokine binding to
the respective a-receptor subunit results in activation of mul-
tiple intracellular signaling pathways regulating proliferation,
diﬀerentiation, survival, and priming or activation of eﬀector
functions [2,3].
Recent studies have reported that the lipid kinase phospha-
tidylinositol 3-kinase (PI3K) is critical for regulation of cyto-
kine-mediated survival in a variety of cells [4]. Critical in
mediating the pro-survival eﬀects of PI3K-activation is the ser-*Corresponding author. Fax: +31 30 2505414.
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doi:10.1016/j.febslet.2004.11.074ine/threonine kinase protein kinase B (PKB/c-Akt) [5]. PKB-
mediated survival has been described in various cell types to
be mediated by phosphorylating and inhibiting components
of the apoptotic machinery, such as the Bcl-2 family members
Bad and Caspase-9, which contain PKB consensus phosphor-
ylation sites (RXRXXS/T) [6,7]. More recently, we and others
have demonstrated that PKB can also inhibit apoptosis
through phosphorylation and inactivation of the FOXO sub-
family of Forkhead transcription factors [8–12]. There are
three mammalian FOXO proteins (FKHR or FOXO1,
FKHR-L1 or FOXO3a, and AFX or FOXO4) homologs of
the Caenorhabditis elegans DAF-16, which are involved in
the regulation of longevity in response to nutrient starvation
[13]. Phosphorylation of FOXO members occurs in nucleus
resulting in the inhibition of DNA-binding, association with
14-3-3 proteins and export of this transcriptionally inactive
complex to cytoplasm [12,14,15]. Previously, it has been dem-
onstrated that cytokine withdrawal can induce cell-cycle arrest
and apoptosis in lymphoid cell lines as a consequence of
FOXO dephosphorylation. FOXO-induced cell cycle arrest
has been attributed to the transcriptional upregulation, and
subsequent increased protein levels, of p27kip1, a CDK inhibi-
tor (CKI) capable of associating with cyclin-CDK complexes
inhibiting their activity [8,9]. Furthermore, FOXO has also
been found to regulate both FasL expression and that of
Bim, a pro-apoptotic Bcl-2 family [9,16,17].
The purpose of this study was to investigate the molec-
ular mechanisms regulating cytokine-mediated erythroblast
survival using the TF-1 cell line as model. It has been
demonstrated that PI3K is required for control of ery-
throid progenitor proliferation and survival [18–20]. How-
ever, until now it is unclear whether cells of the
myeloid/erythroid lineage may also utilize FOXO transcrip-
tion factors to regulate cell survival as has been observed
in lymphocyte cell lines [9,10]. We have found that PI3K
activity is indeed required to maintain cytokine-induced
TF-1 cell survival and this correlates with phosphorylation
and inactivation of FOXO3a. Cytokine deprivation re-
sulted in a dramatic increase of Bim protein levels as well
as cleavage of caspases. Importantly, activation of FOX-
O3a alone was suﬃcient to induce Bim expression and
apoptosis. Finally, addition of a cell-permeable Bim BH3
peptide was suﬃcient to induce apoptosis in TF-1 cells.
These results suggest that inhibitions of the transcriptional
activity of FOXO transcription factors with consequent
suppression of Bim expression are critical events mediating
cytokine-dependent survival of this erythroblastic cell line.blished by Elsevier B.V. All rights reserved.
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2.1. Cells, reagents and antibodies
The IL-5 dependent TF-1 cell line was cultured in serum-free med-
ium, AIM (Gibco, UK), with human IL-5 (1010 M; GlaxoSmithkline,
Stevenage, UK). LY294002, PD098059, SB203580 and SB216763 were
from Alexis (San Diego, CA, USA). Phospho-FOXO3a (Thr32) was
purchased from UBI (Lake Placid, NY, USA) and anti-FasL from
Santa Cruz Biotech. Inc (Santa Cruz, California, USA). Bim poly-
clonal antibody was purchased from Aﬃnity Bioreagents (Golden,
CO, USA). Cleaved caspase-3, cleaved caspase-7, phospho GSK3a/
b(ser9/21), phospho-ERK1/2 (thr202/tyr204), phospho-PKB(ser473)
and phospho-ATF2(thr69/71) were purchased from Cell Signaling
(Beverley, MA, USA). The dephospho-speciﬁc b-catenin antibody
was a kind gift of Dr. Mascha van Noort (UMC Utrecht, The Nether-
lands). The cell permeable peptide (TAT-BH3-Bim) containing the
BH3 domain of Bim linked to the protein transduction sequence of
the HIV TAT protein (YGRKKRRQRRRIR-EIWIAQELRRIG-
DEFNAYY) was synthesized by Fundacio´n Instituto de Inmunologı´a
(Bogota´, Colombia).2.2. Western blotting
For detection of phospho-FOXO3a, phospho-GSK3, phospho-
ERK1/2, phospho-ATF2, phospho-PKB, dephospho-b-catenin, cas-
pase-3, caspase-7, FasL and Bim, TF-1 cells were lysed in Laemmli
sample buﬀer (4% SDS, 20% glycerol and 0.12M Tris–HCl, pH 6.8)
and the lysates were boiled for 5 min. Protein concentration was
determined as described previously [11]. Equal amounts of protein
were separated by SDS–PAGE and Western blotting was performed
using standard techniques. Blots were incubated in blocking buﬀer
(Tris buﬀered saline/Tween 20 (TBST) supplemented with 5% milk)
for 1 h. Antibodies were incubated overnight in TBST supplemented
with 5% milk and detected with swine anti-rabbit or anti-mouse per-
oxidase-conjugated antibody (DAKO, Denmark) and ECL (Amer-
shan, UK).2.3. Apoptosis assays and cell cycle analysis
For apoptosis assays, cells were counted, washed twice with PBS and
resuspended in serum-free medium, AIM (Gibco, UK). Cells were
seeded in 24-well dishes (2 · 105 cells per well) in the presence or ab-
sence of IL-5. After 24 or 48 h incubation, cells were harvested and
stained to detect apoptosis. Rhodamine-123 (Molecular Probes, Eu-
gene, OR, USA) was utilized to assess changes in mitochondrial mem-
brane potential (Dwm). Brieﬂy, cells were incubated in AIM together
with 10 lg/ml Rhodamine-123 at 37 C for 30 min. Cells were washed
once with PBS and analyzed by FACS. The percentage of cells display-
ing low ﬂuorescence represents the population of apoptotic cells, which
is expressed as reduced Dwm [17].
The exposure of phosphatidylserine (PS) was determined by Anexin
V-PE binding (Bender Medsystems; Vienna, Austria). Cells were
washed with PBS and resuspended in binding buﬀer (10 mM HEPES,
pH 7.4; 140 mM NaCl; and 2.5 mM CaCl2). Subsequently, cells were
incubated with Anexin V-PE for 15 min at room temperature in the
dark, washed and resuspended in binding buﬀer. Percentage of apop-
totic cells was detected by FACS analysis.
Cell cycle analysis was also determined. Cells were washed twice in
PBS and ﬁxed for at least 2 h in 300 ll PBS and 700 ll ethanol. Cells
were spun down gently and permeabilized in 200 ll extraction buﬀer
(0.1% Triton X-100, 0.045 M Na2HPO4 and 0.0025 M sodium citrate)
at 37 C for 20 min. Next, 750 ll apoptosis buﬀer (0.1% Triton X-100,
10 mM PIPES, 2 mMMgCl2, 40 lg/ml Rnase, and 20 lg/ml propidium
iodide) was added and incubated for 30 min in the dark. The percent-
age of apoptotic cells was analyzed by FACS as percentage of cells
with a DNA content of <2 N, counting 10 000 cells. Thresholds were
set to gate out cellular debris. Cell cycle proﬁles were determined using
a FACS (Becton and Dickinson, Mountainview, CA, USA) and ana-
lyzed using FACS Express software.
The eﬀect of pharmacological inhibitors (LY294002, PD098059
and SB203580) and TAT-BH3-Bim peptide was assessed by seeding
cells in 24-well dishes (2 · 105 cells per well) in the presence of IL-5
and the corresponding inhibitors. After 48 h incubation, cells were
harvested and Rhodamine-123 staining was performed as indicated
above.2.4. Generation of TF-1 stable transfectants
pBABEPURO-FOXO3a(A3):ER construct was a kind gift of Dr.
Thamar van Dijk (Erasmus University, The Netherlands) [21]. FOX-
O3a(A3):ER retrovirus was produced by transient transfection of the
293T packaging cell line by Fugene transfection reagent (Roche, Al-
mere, The Netherlands), together with the amphotropic packaging
plasmid pCLAmpho. 24 h before transfection, cells were seeded at a
density of 5 · 105 cells/60-mm dish. 30 min before transfection, the
medium was refreshed. 1 lg of pBABE-FOXO3a(A3):ER, 1 lg pCL-
Ampho, 6 ll Fugene and 92 ll of DMEM (Gibco, UK) were carefully
mixed, incubated for 15 min at room temperature and subsequently by
drops added to the cells. After 24 h, the medium was refreshed with
RPMI1640 (Gibco, UK) and after an additional 24 h the viral super-
natant was collected and ﬁltered through a 0.45 lm ﬁlter. Retroviral
transduction was performed by adding 5 ml viral supernatant and
polybrene (8 lg/ml) to 0.5 ml medium containing TF-1 cells (106) in
a 6-wells plate and centrifugation for 1.5 h. 24 h after transduction, in-
fected cells were selected by culturing in the presence of puromycin (2
lg/ml).
2.5. Transient transfection and promoter-luciferase assays
For transient transfections, TF-1 cells were electroporated (0.28 kV;
capacitance, 950 lF) with 16 lg of a luciferase reporter plasmid con-
taining a 0.8 kb enhancer region of the Bim promoter (pGL2-
Bim0.8; [22]), a kind gift of Dr. P. Bouillet (Melbourne, Australia),
or a luciferase reporter containing six FKHRL1 binding sequences
(pGL2-6xDBE; [11]). Cells were co-transfected with 50 ng of a renilla
luciferase plasmid (pRL-TK; Promega) to normalize for transfection
eﬃciency. After transfection, cells were cultured in AIM (Gibco,
UK) with or without cytokine for 24 h. Cells were then harvested, lysed
in luciferase lysis buﬀer (Promega, Leiden, The Netherlands), and
luciferase activity was determined. Values were corrected for transfec-
tion eﬃciency and represent means of at least three independent exper-
iments (±S.D.).3. Results
3.1. Interleukin-5 withdrawal results in cell cycle arrest, loss of
mitochondrial integrity, caspases cleavage and apoptosis
TF-1 is a cytokine-dependent erythroblast cell line derived
from an erythroleukemia patient [23]. We have utilized a clone
of these cells expressing the IL-5 receptor (IL-5R), which re-
quires IL-5 for erythroblast proliferation and survival [24].
TF-1 cells were incubated in the presence or absence of IL-5
(1010 M) for 24 and 48 h, and apoptosis was measured by
binding of Anexin V-FITC to externalized phosphatidylserine
(see Section 2). Following cytokine withdrawal, approximately
20% of the cells were Annexin V-positive after 24 h, which in-
creased to more than 40% after 48 h (Fig. 1A). This indicates
that IL-5 is indeed necessary to inhibit the intrinsic apoptotic
program.
Apoptosis can occur through mitochondrial-dependent and
independent mechanisms [25]. To determine whether induction
of programmed cell death may occur in a mitochondrial-
dependent manner, we analyzed mitochondrial integrity dur-
ing cytokine withdrawal by using Rhodamine-123, a dye that
binds to mitochondria in a membrane potential-dependent
way (Dwm) [17]. Indeed, in IL-5-starved cells, signiﬁcant loss
of Dwm was already observed after 24 h, and this increased
dramatically over time (Fig. 1B). Thus in TF-1 cells, cytokine
withdrawal-induced apoptosis correlates with mitochondrial
depolarization, suggesting a role in initiation of the apoptotic
program.
We also investigated the eﬀect of cytokine withdrawal on cell
cycle progression (see Section 2). Addition of IL-5 is necessary
for TF-1 proliferation, and upon 24 h cytokine-deprivation
Fig. 1. IL-5 withdrawal induces TF-1 apoptosis, mitochondrial membrane-depolarization and caspase cleavage. TF-1 cells were incubated in serum-
free medium (AIM) in the presence or absence of IL-5 (1010 M) for the times indicated. (A) Cells were treated with Annexin-PE and analyzed by
FACS. (B) Mitochondrial transmembrane depolarization was assessed using Rhodamine-123 staining and analyzed by FACS. (C) Cells were
permeabilized and stained with PI as indicated in Section 2. Apoptotic cells were analyzed by FACS as percentage of cells with a DNA content of <2
N, counting 10 000 cells. These data are representatives of three independent experiments. (D) TF-1 cells were cytokine starved in serum-free medium
for the times indicated and cell lysates prepared. Equal amounts of protein were analyzed by SDS–PAGE followed by Western blotting with the
appropriate cleaved-caspase antibodies as indicated. These data are representatives of at least three independent experiments.
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1C). There is also a substantial increase in cells undergoing
apoptosis as measured by a DNA content less than 2 N chro-
mosomes, the sub-G1 peak. This was further increased at 48 h,
corroborating the data observed with annexin V and Rh123
staining.
The kinetics of the apoptotic process described above corre-
lated with the activation of caspases. Using activation-speciﬁc
antibodies, we found also cleavage of both caspase-3 and cas-
pase-7 within 24 h of IL-5 withdrawal (Fig. 1D). Taken to-
gether, these results show that TF-1 cells undergo
programmed cell death in the absence of cytokine, and this
correlates with both mitochondria-depolarization and caspase
activation.
3.2. PI3K activity is necessary for TF-1 survival
To deﬁne the intracellular signaling pathways required for
cytokine mediated cell survival, we analyzed the eﬀect of sev-
eral pharmacological kinase inhibitors on TF-1 cells cultured
in the presence of IL-5. Cells were cultured for 48 h and mito-
chondrial membrane depolarization was measured as de-
scribed above. Cell survival was unaﬀected when cells were
treated with PD098059 (mitogen-activated protein kinase ki-
nase (MEK) inhibitor), or SB203580 (p38 MAPK inhibitor),
suggesting that these MAP kinases do not play a critical role
in IL-5-dependent survival (Fig. 2A). In contrast, pre-incubation
of cells with the PI3K inhibitor, LY294002, resulted in
ablation of the protective eﬀects of IL-5 and induction of
apoptosis. The serine/threonine kinase GSK-3 is dephospho-
rylated and activated as a consequence of inhibition of
PI3K. GSK-3 has also been implicated in regulating apoptosis
and thus could potentially modulate the eﬀects seen by PI3Kinhibition. To investigate this, we pre-treated TF-1 cells with
two alternative inhibitors for GSK-3 (SB216763 and LiCl) be-
fore cytokine withdrawal. Cells cultured with SB21673 and
LiCl after IL-5 withdrawal did not have a survival advantage
(Fig. 2). This suggests that GSK-3 is not responsible for the
induction of apoptosis observed after cytokine withdrawal.
To conﬁrm that the various inhibitors were indeed active,
TF-1 cells were pre-treated with or without inhibitors, stimu-
lated with IL-5 and protein lysates prepared. As is shown in
Fig. 2B, LY294002, PD098059 and SB20350 are able to block
PKB, ERK1/2 and p38 phosphorylation, respectively. To
analyze GSK-3 activity, we utilized a dephosphospeciﬁc anti-
body that only reacts with the non-phosphorylated form of
b-catenin [26]. As seen in the lower panel, SB216763 indeed
blocks GSK-3 mediated b-catenin phosphorylation in TF-1
cells after cytokine withdrawal. Taken together, these data
demonstrate that PI3K activity is necessary for TF-1 survival,
and this appears to occur independently of GSK-3 activity.3.3. IL-5 inhibits FOX3a and suppresses expression of Bim
To further investigate the molecular mechanisms involved in
PI3K-dependent survival, we analyzed the eﬀect of IL-5 on
FOXO3a, a pro-apoptotic Forkhead transcription factor,
inhibited by PI3K signaling [12,14]. We ﬁrst determined
whether FOXO3a was indeed phosphorylated following IL-5
stimulation. Phosphorylation of FOXO3a was optimal after
15–30 min addition of IL-5 and declined to basal levels after
several hours (Fig. 3). In contrast, phosphorylation and inacti-
vation of GSK-3 after IL-5 stimulation was sustained. How-
ever, as detailed above, GSK-3 does not appear to mediate
cytokine withdrawal apoptosis of TF-1 cells.
Fig. 2. PI3K activity is required for TF-1 survival. (A) TF-1 cells were incubated in serum-free medium with or without IL-5 (1010 M) for 48 h.
Pharmacological inhibitors were added at the concentrations indicated. Mitochondrial transmembrane depolarization was assessed using
Rhodamine-123 staining as described above. These data are representatives of three independent experiments. (B) TF-1 cells were incubated in serum
free medium with or without IL-5 (1010 M) for 10 min, in the absence or presence of kinase inhibitors as indicated. Cell lysates were prepared and
analyzed by Western blotting with activation speciﬁc phospho-antibodies as shown. LY294002 (25 lM), PD098059 (50 lM), SB203580 (10 lM) and
SB216763 (10 lM).
Fig. 3. IL-5 induces phosphorylation of FOXO3a and GSK-3. TF-1
cells were cytokine starved overnight in serum-free medium. After 16 h,
cells were stimulated with IL-5 (1010 M) for the times indicated.
Equal amounts of protein were run on SDS–PAGE followed by
Western blotting with a anti-FOXO3a (Thr32) or anti-GSK-3 (Ser9/
21). These data are representatives of three independent experiments.
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role in regulating apoptosis by inducing transcription of Fas
ligand (FasL) [16]. To determine whether indeed FasL was ex-
pressed upon IL-5 withdrawal, TF1 erythroblasts were cyto-
kine starved and lysates analyzed for expression. We were
unable to detect expression of FasL in TF1 cells either in the
presence or absence of IL-5 (Fig. 4A). As a positive control,
we analyzed the expression in Jurkat T cells and LS174 cells
both of which have been reported to express FasL. Indeed,
we detected high levels of FasL in both types of cells (Fig.
4A). This argues against FasL being a target of FOXO3a in
TF-1 cells. Furthermore, addition of Fas cross-linking anti-bodies had no eﬀect on TF-1 survival (data not shown). Thus,
the onset of apoptosis after cytokine withdrawal occurs inde-
pendently of FasR–FasL interactions.
FOXO activity has also been found to regulate the expres-
sion of the pro-apoptotic Bcl-2 family member Bim [11,17].
Thus, we also analyzed the expression of Bim in the presence
or absence of IL-5. We found that Bim expression was dramat-
ically upregulated when TF-1 erythroblasts were deprived of
IL-5 (Fig. 4B). To determine whether this upregulation oc-
curred at the level of transcriptional regulation, we transfected
TF-1 cells with either a FOXO (6xDBE; [22]), or a Bim pro-
moter luciferase-reporter construct (Bim 0.8; [11]). Indeed,
cytokine withdrawal resulted in upregulation of both 6xDBE
and Bim promoter reporter activity. This suggests that Bim
is indeed transcriptionally regulated by FOXO in TF-1 cells
after cytokine withdrawal.
Previous studies on BH3-only Bcl-2 family members have
shown that the BH3 domain plays an important role in induc-
ing cell death by binding and antagonizing pro-survival Bcl-2
family members [27]. To determine whether Bim upregulation
itself was suﬃcient to induce apoptosis, we treated cells with
increasing concentrations of TAT-BH3-Bim (a cell permeable
peptide containing the sequence of the BH3 domain of Bim
linked to the 11 amino acids protein-transduction sequence
of the HIV tat protein) in the presence of IL-5. Apoptosis
was measured by Rh123 staining after 48 h as described previ-
ously. We observed that TAT-BH3-Bim alone was suﬃcient
to potently induce apoptosis in a dose-dependent fashion
(Fig. 4D). Treatment of cells with increasing concentrations
of a control peptide had no eﬀect on cell survival (Fig. 4D;
TAT-control).
Fig. 4. IL-5-withdrawal induces Bim but not Fas Ligand expression in TF-1 cells. (A) TF-1 cells were cytokine starved in serum-free medium for the
times indicated. As a positive control for FasL expression, Jurkat T cells and LS174 cells were utilized. Equal amounts of protein were analyzed by
SDS–PAGE followed by Western blotting with anti-FasL antibody. (B) TF-1 cells were cytokine starved in serum-free medium for the times
indicated. Equal amounts of protein were analyzed by SDS–PAGE followed by Western blotting with anti-Bim antibody. (C) TF-1 cells were
electroporated with either a FOXO3a (6xDBE) or Bim promoter (Bim 0.8) reporter-luciferase construct. After transfection, cells were either
incubated with or without cytokine and 24 h later luciferase activity measured. The data represent three independent experiments. (D) TF-1 cells were
incubated for 48 h in serum-free medium with IL-5 and a synthetic TAT-peptide containing the sequence of the BH3 domain of Bim (concentrations
indicated), or a control TAT-peptide. Apoptosis was assessed by measuring mitochondrial transmembrane depolarization using Rhodamine-123
staining as described in Section 2.
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FOXO3a activation, Bim expression and that this is suﬃcient
to induce programmed cell death in TF-1 erythroblasts.
3.4. FOXO3a activation upregulates Bim expression and results
in apoptosis
To determine whether FOXO3a activation is indeed suﬃ-
cient to induce apoptosis in TF-1 cells, we generated a poly-
clonal cell line expressing a 4-hydroxytamoxifen (4-OHT)
inducible FOXO3a construct, FOXO3a(A3):ER\ [11]. Addi-
tion of 4-OHT to these cells results in the rapid nuclear trans-
location and transcriptional activation of FOXO3a. Control
cells (TF-1 CON) or FOXO3a(A3):ER\ cells (TF-1 FOXO3a)
were cultured in the presence of IL-5, with or without 4-OHT
(Fig. 5A). As shown in the upper panels, addition of 4-OHT to
the control TF-1 cells had no eﬀect on the numbers of apopto-
tic cells. In contrast, addition of 4-OHT to the FOXO3a TF-1
cells resulted in a dramatic increase in apoptosis after 24 h.
These data demonstrate that activation of FOXO3a alone is
suﬃcient to induce an apoptotic program in TF-1 cells.
We next wished to determine whether FOXO3a activation
was also suﬃcient to upregulate Bim expression. TF-1 FOX-
O3a cells were treated with or without 4-OHT for 24 h and
protein lysates prepared. These were analyzed for Bim expres-
sion by Western blotting. As can be seen in Fig. 5B, FOXO3a
activation alone is indeed suﬃcient to increase Bim expression
in TF-1 cells.4. Discussion
Survival of hematopoietic cells is regulated by growth fac-
tors that modulate intracellular signaling pathways to repress
the activation of an intrinsic apoptotic program. We have uti-
lized TF-1 erythroblasts as a cytokine-dependent model and
have demonstrated that PI3K is required for cytokine-
mediated protection from apoptosis. Upon receptor activation,
PI3K localizes to the plasma membrane and generates 3 0-phos-
phorylated phosphatidylinositide lipids, which are critical for
activation of PKB (reviewed in [6]). Activation of PKB then
leads to phosphorylation of a variety of proteins proposed to
play a role in the regulation of apoptosis. The pro-apoptotic
Bcl-2 family member Bad was initially identiﬁed as a direct
PKB substrate, which upon phosphorylation binds to cytosolic
14-3-3 preventing its relocation to mitochondria [28]. PKB has
also been reported to caspase-9 inhibiting its protease activity,
although the physiological relevance of this remains unclear
[29]. Transcription of pro-survival genes is also essential to
prevent cell death. Thus, PKB can promote survival by phos-
phorylating IKKs, which induce phosphorylation of IjBs and
further transcription activity of NFjB. So far, the pro-survival
Bcl-2 family members Bﬂ-1/A1 and Bcl-XL have been found to
be upregulated as a consequence of NFjB activity [30,31].
More recently, activation of PI3K-PKB has been demon-
strated to result in phosphorylation of the members of the
FOXO Forkhead transcription factor family, inhibiting their
Fig. 5. FOXO3a activation is suﬃcient to induce both TF-1 apoptosis and Bim expression. (A) Stable TF-1 cell lines were generated expressing either
an empty pBABE vector (TF-1 CON; upper panels) or pBABE-FOXO3a(A3):ER\ (TF-1 FOXO3a; lower panels) as described in Section 2. Cells
were cultured with IL-5 (1010 M) and treated with or without 4-OHT (100 nM) for 24 h as indicated. Apoptosis was measured by analysis of
Annexin V-FITC binding as described above. (B) TF-1 FOXO3a cells were treated for 24 h with or without 4-OHT and protein lysates prepared.
Samples were analyzed by Western blotting for Bim expression.
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that FOXO3a phosphorylation was indeed regulated in a
cytokine-dependent manner. Cytokine withdrawal results in
dephosphorylation and thus subsequent activation of this
transcription factor correlating with induction of apoptosis
(Fig. 3). It has been proposed that one mechanism by which
FOXOs can induce apoptosis is through transcriptional
induction of the death-receptor ligand FasL [15]. However,
following IL-5 withdrawal, we found neither expression of
FasL, nor cleavage of caspase-8 (data not shown), a hall-
mark of Fas-induced cell death. This indicates that in
TF-1 cells, apoptosis occurs through a death receptor-
independent mechanism. Activation of FOXO3a, resulting
in transcriptional upregulation of the pro-apoptotic Bcl-2
member Bim, appears to be a critical event in initiating pro-
grammed cell death after IL-3 and IL-2 withdrawal in lym-
phocytes [9,11]. Recently, analysis of the Bim promoter has
identiﬁed FOXO binding sites and mutation blocked FOXO-
induced transcription [32]. Indeed, in TF-1 cells cytokine
withdrawal leads to both activation of FOXO3a, transcrip-
tional upregulation of the Bim promoter and an increase
in Bim protein expression (Figs. 3 and 4). Furthermore, spe-
ciﬁc activation of FOXO3a in TF-1 cells alone is suﬃcient
to increase Bim expression levels (Fig. 5B). Although the
precise molecular mechanism utilized by Bim to antagonize
Bcl- 2 molecules is not completely understood, it has been
shown that Mcl-1 selectively inhibits Bim in lymphocytes,
maintaining cell survival during lymphoid development
[33]. Interestingly, Mcl-1 has also been associated with cell
survival mediated by IL-5 and stem cell factor (SCF) in
TF-1 cells, where its expression is connected to the activa-
tion of PI3K/PKB and MEK/MAPK pathways [34].We conﬁrmed that expression of Bim is suﬃcient to induce
TF-1 apoptosis by introducing a cell-permeable Bim-BH3 pep-
tide into TF-1 cells (Fig. 4D). This peptide induced a potent,
dose-dependent induction of apoptosis. Studies on BH3-only
proteins have suggested that BH3 domains (alpha helical pep-
tides) induce apoptosis either by activating pro-apoptotic pro-
teins (Bak, Bax) or antagonizing the role of anti-apoptotic
proteins (Bcl-2, Bcl-XL) on mitochondria [35,36]. Recently,
structural analysis of the Bcl-XL/Bim complex demonstrated
that the BH3 domain of Bim is an alpha helix longer than
those observed in other Bcl-2 family members, which facilitates
its interaction with Bcl-XL. Presumably, Bim can also utilize its
BH3 domain to interact with Bax and stabilize its structure
when it is activated during apoptosis [37]. Alpha helical pep-
tides, especially those charged positively, can induce toxic
activity by binding negatively charged membranes [38]. We ex-
cluded that the apoptotic activity of Bim-BH3 peptide was due
to the presence of the TAT sequence (rich in arginines and ly-
sines), since a control TAT-peptide did not have any eﬀect on
cell survival (see Fig. 4D). The use of such cell-permeable BH3
mimetics directly targeting the mitochondria may indeed be
useful in the treatment of a variety of malignancies.
Recently, it was reported that growth factor-deprived ery-
throblasts were protected from apoptosis by using lithium
chloride an inhibitor for GSK-3 [39]. Although we found phos-
phorylation of GSK-3 by IL-5 stimulation (Fig. 3), these data
are in contrast to our own, since we found no protective eﬀect
of GSK-3 inhibition (Fig. 2). One explanation might be the
potentially aspeciﬁc eﬀects of lithium chloride treatment com-
pared to the use of SB216763 [40].
In this study, we have demonstrated the activation of FOX-
O3a, as well as upregulation of Bim upon cytokine withdrawal
M. Rosas et al. / FEBS Letters 579 (2005) 191–198 197in TF-1 erythroblasts. These ﬁndings can be compared with
the signals found when cytokines are depleted from lympho-
cytes [9,11]. Similar to lymphocytes, TF-1 cells also utilize
PI3K as a survival factor sensor to make decisions concerning
whether cells should live or die. Thus, PI3K-mediated FOXO
inhibition appears to be a general signaling pathway utilized
by a wide variety of hematopoietic lineages to regulate cell
survival.
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